UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~September~~March 3010, ~~2024~~ 2025

~~Intorio~~REDOX INTERNATIONAL GROUP, Corp.

(Exact name of registrant as specified in its charter)

Nevada

(State or other jurisdiction
of incorporation)

333-255055
(Commission
File Number)

98-1578603
(IRS Employer
Identification No.)

17875 Von Karman Avenue,

Irvine, California 92614

(Address of Principal Executive Offices)

(323) 909-2866

Registrant’s telephone number, including area code:

~~______________________________________~~Intorio, Corp.

(Former name or former address, if changed since last report.)

Copies to:

Donald P. Hateley, Esq.

The Hateley Firm, APC

620 Newport Center Drive, Suite 1100

Newport Beach, CA 92660

Phone: (949) 438-1040

Fax: (310) 388-5899

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered N/A N/A N/A

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

~~Item~~ITEM 5.0203 ~~Departure~~Amendments to Articles of ~~Directors~~Incorporation or ~~Principal Officers~~Bylaws; ~~Election~~Change ofin ~~Directors;~~Fiscal ~~Appointment of Principal Officers.~~Year

~~Effective~~On ~~September~~March 3010, ~~2024~~2025, ~~Han-Wen~~Intorio, Corp. Ou(the ~~resigned as~~“Company”) ~~Secretary~~amended and restated its Articles of ~~the~~Incorporation ~~Corporation~~to: (i) change its name to Redox International Group, Corp., and Li(ii) Yuauthorize 75,000,000, $0.0001 par value preferred stock. This changed was ~~appointed~~approved ~~Secretary~~by inthe ~~his~~board ~~place~~of directors and the majority of the shareholders.

The ~~business~~Certificate ~~background~~of ~~descriptions~~Amendment to the Articles of ~~the~~Incorporation ~~newly appointed~~describe ~~officer~~above is filed as ~~follows:~~an exhibit to this Current Report on Form 8-K. The description is qualified in its entirety by reference to the full extent of such document.

LiITEM Yu9.01 -Financial ~~Secretary~~Statements and Exhibits.

LiExhibit Yu3.1.1 ~~currently~~Certificate ~~has~~of ~~served~~Amendment asto ~~the~~Articles ~~Vice~~of ~~President~~Incorporation ofwith ~~Legal~~respect ~~and~~to ~~Operations~~the atname ~~VitaSpring Biomedical since January 2024. From May 2022 through Janaury 2024~~change, Linumber Yuof ~~worked~~shares asof acommon ~~Consultant for~~stock ~~VitaSpring Biomedical,~~ and ~~from~~the ~~January~~preferred ~~2020~~stock ~~through~~and ~~April~~reverse ~~2022, he was a Financial Service Professional at New York Life~~split.

Mr. Yu graduated from the California State University, Long Beach, California with a Mast of Business Administration.

Exhibit

Number

Description

3.1.1

Certificate of Amendment to Articles of Incorporation with respect to the name change and the number of shares of common stock and the preferred stock.

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	INTORIO, CORP.
	REDOX INTERNATIONAL GROUP, CORP.
Dated: October 8, 2024	By:	/s/ Han-Wen Ou
Dated: June 16, 2025	By:	/s/ Han-Wen Ou
	Name:	Han-Wen Ou
	Title:	~~CEO~~Chief Executive Officer

Filing Compare · Redox International Group, Corp.